The folks at SylvanSport have improved on the concept a bit with the new, collapsable, three-mode pop-up camper trailer. It's ...

Venturing into a boatless carp fishing adventure, I'm excited to share my simple yet effective rigs with you. In this episode ...

A solid setup is the foundation for any good golf swing. Here are five things you can do to develop a proper setup.

Doechii took a moment out of her performance at All Things Go Festival in New York City on Saturday to show her support for Lola Young after the singer collapsed onstage earlier in the night. The ...

Kodiak Robotics will have a new name and a fresh opportunity to pitch its efforts to automate commercial trucking when the maker of software for self-driving vehicles makes its public-market debut.

New York mayoral candidate Zohran Mamdani made a surprise appearance at All Things Go 2025 during its New York edition at Forest Hills Stadium on Friday. Mamdani joined Lucy Dacus, one of the ...

Tony is here with his Lenovo Legion Go 2 review, and the awaited second-generation handheld gaming console with detachable controllers had to deliver a lot to justify the $1,199 starting price. While ...

BTC must clear the next significant resistance level to unlock targets at $127,000–$137,000. On-chain data shows room to run, with $122,000 and $138,000 as the key risk levels. Bitcoin (BTC) closed ...

A fundraiser has been set up to help with medical bills for Kevin Norfleet, who was shot and returned fire after finding a teen rummaging through his vehicle, according to family and police.

ASTER eyes a 35% rebound from key support, with a breakout setup that could send the token back toward record highs in October. ASTER defends hot support at $1.60–$1.80 for a potential 35% rebound ...

Debate over Americans’ healthcare costs has led to a government shutdown, as lawmakers feud over how much the federal government should chip in on subsidies for people on Obamacare plans. The ...

AstraZeneca shares rallied on Wednesday after the U.K.-based pharmaceuticals giant and its Japanese partner said the Food and Drug Administration was reviewing one of its drugs to treat breast cancer.